Literature DB >> 15380106

Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol eta and REVl protein.

Agnès Tissier1, Patricia Kannouche, Marie-Pierre Reck, Alan R Lehmann, Robert P P Fuchs, Agnès Cordonnier.   

Abstract

The progress of replicative DNA polymerases along the replication fork may be impeded by the presence of lesions in the genome. One way to circumvent such hurdles involves the recruitment of specialized DNA polymerases that perform limited incorporation of nucleotides in the vicinity of the damaged site. This process entails DNA polymerase switch between replicative and specialized DNA polymerases. Five eukaryotic proteins can carry out translesion synthesis (TLS) of damaged DNA in vitro, DNA polymerases zeta, eta, iota, and kappa, and REV1. To identify novel proteins that interact with hpol eta, we performed a yeast two-hybrid screen. In this paper, we show that hREV1 interacts with hpol eta as well as with hpol kappa and poorly with hpol iota. Furthermore, cellular localization analysis demonstrates that hREV1 is present, with hpol eta in replication factories at stalled replication forks and is tightly associated with nuclear structures. This hREV1 nuclear localization occurs independently of the presence of hpol eta. Taken together, our data suggest a central role for hREV1 as a scaffold that recruits DNA polymerases involved in TLS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380106     DOI: 10.1016/j.dnarep.2004.06.015

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  98 in total

1.  Multifaceted recognition of vertebrate Rev1 by translesion polymerases ζ and κ.

Authors:  Jessica Wojtaszek; Jiangxin Liu; Sanjay D'Souza; Su Wang; Yaohua Xue; Graham C Walker; Pei Zhou
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

2.  The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase.

Authors:  Lauren S Waters; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

Review 3.  DNA polymerases and somatic hypermutation of immunoglobulin genes.

Authors:  Mineaki Seki; Patricia J Gearhart; Richard D Wood
Journal:  EMBO Rep       Date:  2005-12       Impact factor: 8.807

4.  Involvement of Rad18 in somatic hypermutation.

Authors:  Jürgen Bachl; Isin Ertongur; Berit Jungnickel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

5.  Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage.

Authors:  Caixia Guo; Tie-Shan Tang; Marzena Bienko; Joanne L Parker; Aleksandra B Bielen; Eiichiro Sonoda; Shunichi Takeda; Helle D Ulrich; Ivan Dikic; Errol C Friedberg
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

6.  Identification of a novel REV1-interacting motif necessary for DNA polymerase kappa function.

Authors:  Eiji Ohashi; Tomo Hanafusa; Keijiro Kamei; Ihnyoung Song; Junya Tomida; Hiroshi Hashimoto; Cyrus Vaziri; Haruo Ohmori
Journal:  Genes Cells       Date:  2009-01-06       Impact factor: 1.891

7.  REV1 is implicated in the development of carcinogen-induced lung cancer.

Authors:  Chad A Dumstorf; Suparna Mukhopadhyay; Elangovan Krishnan; Bodduluri Haribabu; W Glenn McGregor
Journal:  Mol Cancer Res       Date:  2009-01-27       Impact factor: 5.852

8.  Complex formation of yeast Rev1 with DNA polymerase eta.

Authors:  Narottam Acharya; Lajos Haracska; Satya Prakash; Louise Prakash
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

9.  PCNA-Ub polyubiquitination inhibits cell proliferation and induces cell-cycle checkpoints.

Authors:  Zhoushuai Qin; Zhiqiang Bai; Ying Sun; Xiaohong Niu; Wei Xiao
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

10.  DNA damage tolerance: when it's OK to make mistakes.

Authors:  Debbie J Chang; Karlene A Cimprich
Journal:  Nat Chem Biol       Date:  2009-01-15       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.